Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth.,Nature Chemical Biology

当前位置： X-MOL 学术 › Nat. Chem. Biol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth.
Nature Chemical Biology ( IF 14.8 ) Pub Date : 2021-08-01 , DOI: 10.1038/s41589-021-00843-1
Bianca J Lee ₁ , Jacob A Boyer _{2,

3} , G Leslie Burnett ₄ , Arun P Thottumkara ₄ , Nidhi Tibrewal ₅ , Stacy L Wilson ₁ , Tientien Hsieh ₅ , Abby Marquez ₅ , Edward G Lorenzana ₁ , James W Evans ₁ , Laura Hulea _{6,

7,

8} , Gert Kiss ₅ , Hui Liu ₉ , Dong Lee ₁₀ , Ola Larsson ₉ , Shannon McLaughlan ₆ , Ivan Topisirovic ₆ , Zhengping Wang ₁₀ , Zhican Wang ₁₀ , Yongyuan Zhao ₁₀ , David Wildes ₁ , James B Aggen ₄ , Mallika Singh ₁ , Adrian L Gill ₄ , Jacqueline A M Smith ₁ , Neal Rosen ₃

Affiliation

Department of Biology, Revolution Medicines, Inc., Redwood City, CA, USA.
Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA.
Department of Chemistry, Revolution Medicines, Inc., Redwood City, CA, USA.
Department of Discovery Technologies, Revolution Medicines, Inc., Redwood City, CA, USA.
Gerald Bronfman Department of Oncology and Departments of Biochemistry and Experimental Medicine, Lady Davis Institute, McGill University, Montréal, QC, Canada.
Département de Médecine, Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, QC, Canada.
Maisonneuve-Rosemont Hospital Research Centre, Montréal, QC, Canada.
Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institute, Solna, Sweden.
Department of Non-clinical Development and Clinical Pharmacology, Revolution Medicines, Inc., Redwood City, CA, USA.